Review





Similar Products

blocking solution  (Boster Bio)
90
Boster Bio blocking solution
Blocking Solution, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tlr7/pmc12978692-74-8-13?v=Boster+Bio
Average 90 stars, based on 1 article reviews
blocking solution - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
tlr7  (Proteintech)
93
Proteintech tlr7
Effect of BSHXR on the expression of inflammatory factors. (A) The mRNA expression of TLR2, TLR4, and <t>TLR7</t> in decidual tissue (n = 6). (TLR2: Con vs. RSA, p = 0.0036; RSA vs. CsA, p = 0.0443; RSA vs. BSHXR, p = 0.0034; TLR4: Con vs. RSA, p = 0.0097; RSA vs. CsA, p = 0.0260; RSA vs. BSHXR, p = 0.0051; TLR7: Con vs. RSA, p = 0.0104; RSA vs. CsA, p = 0.0315; RSA vs. BSHXR, p = 0.0229). (B) Representative images of immunofluorescence staining for TLR2, TLR4, and TLR7 in decidual tissues. Scale bar: 50 μm. (C) The protein expression of TLR2, TLR4, and TLR7 in decidual tissue. (D) Quantification of the protein levels (n = 3). (TLR2: Con vs. RSA, p = 0.0062; RSA vs. CsA, p = 0.0158; RSA vs. BSHXR, p = 0.0222; TLR4: Con vs. RSA, p = 0.0001; RSA vs. CsA, p = 0.0001; RSA vs. BSHXR, p < 0.0001; TLR7: Con vs. RSA, p = 0.0099; RSA vs. CsA, p = 0.0129; RSA vs. BSHXR, p = 0.0045). The results are expressed as the means ± SEMs. ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001, compared with the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 and, ### p < 0.0001, compared with the RSA group.
Tlr7, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tlr7/pmc12957807-71-6-14?v=Proteintech
Average 93 stars, based on 1 article reviews
tlr7 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
immunohistochemistry  (Proteintech)
93
Proteintech immunohistochemistry
Effect of BSHXR on the expression of inflammatory factors. (A) The mRNA expression of TLR2, TLR4, and <t>TLR7</t> in decidual tissue (n = 6). (TLR2: Con vs. RSA, p = 0.0036; RSA vs. CsA, p = 0.0443; RSA vs. BSHXR, p = 0.0034; TLR4: Con vs. RSA, p = 0.0097; RSA vs. CsA, p = 0.0260; RSA vs. BSHXR, p = 0.0051; TLR7: Con vs. RSA, p = 0.0104; RSA vs. CsA, p = 0.0315; RSA vs. BSHXR, p = 0.0229). (B) Representative images of immunofluorescence staining for TLR2, TLR4, and TLR7 in decidual tissues. Scale bar: 50 μm. (C) The protein expression of TLR2, TLR4, and TLR7 in decidual tissue. (D) Quantification of the protein levels (n = 3). (TLR2: Con vs. RSA, p = 0.0062; RSA vs. CsA, p = 0.0158; RSA vs. BSHXR, p = 0.0222; TLR4: Con vs. RSA, p = 0.0001; RSA vs. CsA, p = 0.0001; RSA vs. BSHXR, p < 0.0001; TLR7: Con vs. RSA, p = 0.0099; RSA vs. CsA, p = 0.0129; RSA vs. BSHXR, p = 0.0045). The results are expressed as the means ± SEMs. ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001, compared with the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 and, ### p < 0.0001, compared with the RSA group.
Immunohistochemistry, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tlr7/pm41684130-83-4-10?v=Proteintech
Average 93 stars, based on 1 article reviews
immunohistochemistry - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
anti tlr7 8  (Merck & Co)
86
Merck & Co anti tlr7 8
Effect of BSHXR on the expression of inflammatory factors. (A) The mRNA expression of TLR2, TLR4, and <t>TLR7</t> in decidual tissue (n = 6). (TLR2: Con vs. RSA, p = 0.0036; RSA vs. CsA, p = 0.0443; RSA vs. BSHXR, p = 0.0034; TLR4: Con vs. RSA, p = 0.0097; RSA vs. CsA, p = 0.0260; RSA vs. BSHXR, p = 0.0051; TLR7: Con vs. RSA, p = 0.0104; RSA vs. CsA, p = 0.0315; RSA vs. BSHXR, p = 0.0229). (B) Representative images of immunofluorescence staining for TLR2, TLR4, and TLR7 in decidual tissues. Scale bar: 50 μm. (C) The protein expression of TLR2, TLR4, and TLR7 in decidual tissue. (D) Quantification of the protein levels (n = 3). (TLR2: Con vs. RSA, p = 0.0062; RSA vs. CsA, p = 0.0158; RSA vs. BSHXR, p = 0.0222; TLR4: Con vs. RSA, p = 0.0001; RSA vs. CsA, p = 0.0001; RSA vs. BSHXR, p < 0.0001; TLR7: Con vs. RSA, p = 0.0099; RSA vs. CsA, p = 0.0129; RSA vs. BSHXR, p = 0.0045). The results are expressed as the means ± SEMs. ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001, compared with the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 and, ### p < 0.0001, compared with the RSA group.
Anti Tlr7 8, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tlr7/pmc13016103-6-2-18?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
anti tlr7 8 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Effect of BSHXR on the expression of inflammatory factors. (A) The mRNA expression of TLR2, TLR4, and TLR7 in decidual tissue (n = 6). (TLR2: Con vs. RSA, p = 0.0036; RSA vs. CsA, p = 0.0443; RSA vs. BSHXR, p = 0.0034; TLR4: Con vs. RSA, p = 0.0097; RSA vs. CsA, p = 0.0260; RSA vs. BSHXR, p = 0.0051; TLR7: Con vs. RSA, p = 0.0104; RSA vs. CsA, p = 0.0315; RSA vs. BSHXR, p = 0.0229). (B) Representative images of immunofluorescence staining for TLR2, TLR4, and TLR7 in decidual tissues. Scale bar: 50 μm. (C) The protein expression of TLR2, TLR4, and TLR7 in decidual tissue. (D) Quantification of the protein levels (n = 3). (TLR2: Con vs. RSA, p = 0.0062; RSA vs. CsA, p = 0.0158; RSA vs. BSHXR, p = 0.0222; TLR4: Con vs. RSA, p = 0.0001; RSA vs. CsA, p = 0.0001; RSA vs. BSHXR, p < 0.0001; TLR7: Con vs. RSA, p = 0.0099; RSA vs. CsA, p = 0.0129; RSA vs. BSHXR, p = 0.0045). The results are expressed as the means ± SEMs. ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001, compared with the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 and, ### p < 0.0001, compared with the RSA group.

Journal: Journal of Traditional and Complementary Medicine

Article Title: Bushen Huoxue Recipe enhances the immune microenvironment at the maternal-fetal interface via the Hippo signaling pathway in mice with recurrent spontaneous abortion

doi: 10.1016/j.jtcme.2025.02.005

Figure Lengend Snippet: Effect of BSHXR on the expression of inflammatory factors. (A) The mRNA expression of TLR2, TLR4, and TLR7 in decidual tissue (n = 6). (TLR2: Con vs. RSA, p = 0.0036; RSA vs. CsA, p = 0.0443; RSA vs. BSHXR, p = 0.0034; TLR4: Con vs. RSA, p = 0.0097; RSA vs. CsA, p = 0.0260; RSA vs. BSHXR, p = 0.0051; TLR7: Con vs. RSA, p = 0.0104; RSA vs. CsA, p = 0.0315; RSA vs. BSHXR, p = 0.0229). (B) Representative images of immunofluorescence staining for TLR2, TLR4, and TLR7 in decidual tissues. Scale bar: 50 μm. (C) The protein expression of TLR2, TLR4, and TLR7 in decidual tissue. (D) Quantification of the protein levels (n = 3). (TLR2: Con vs. RSA, p = 0.0062; RSA vs. CsA, p = 0.0158; RSA vs. BSHXR, p = 0.0222; TLR4: Con vs. RSA, p = 0.0001; RSA vs. CsA, p = 0.0001; RSA vs. BSHXR, p < 0.0001; TLR7: Con vs. RSA, p = 0.0099; RSA vs. CsA, p = 0.0129; RSA vs. BSHXR, p = 0.0045). The results are expressed as the means ± SEMs. ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001, compared with the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 and, ### p < 0.0001, compared with the RSA group.

Article Snippet: Antibodies against TLR2 (66645-1-Ig), TLR4 (66350-1-Ig), TLR7 (17232-1-AP), and GAPDH (60004-1-Ig) were purchased from Proteintech (Rosemont, IL, USA); antibodies against RORγt (ab207082) and FoxP3 (ab215206) were purchased from Abcam (Cambridge, MA, USA); Alexa Fluor 555 nm (8953) and antibodies against MST (14946), p-MST (49332), LATS (3477S), p-LATS (8654S), YAP (14074S), p-YAP (13008S), TAZ (83669S), and p-TAZ (59971S) were purchased from Cell Signaling Technology (Danvers, MA, USA); and an antibody against Lamin B (A11495) was purchased from ABclonal (Wuhan, China).

Techniques: Expressing, Immunofluorescence, Staining, Control